Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

GVS SpA

GVS SpA

Actions
IndustrialsGeneral Industrials
  • Price (EUR)7.10
  • Today's Change-0.08 / -1.11%
  • Shares traded6.58k
  • 1 Year change+38.67%
  • Beta0.4637
Data delayed at least 15 minutes, as of Sep 30 2024 09:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GVS SpA is an Italy-based manufacturer of filters and components for applications in the healthcare, life sciences, automotive, appliance, safety, commercial and industrial filtration. Its offering includes seven product lines: Healthcare, Laboratory, Mobility, Air Safety, Appliance, Personal Safety and Membranes. Each product line provides a suite of customizable solutions specifically related to each market. Additionally, the Company offers tailormade product and process development services, which cover all the project stages, including product and process design, validation, up to the mass production for large quantities. It is active globally.

  • Revenue in EUR (TTM)426.19m
  • Net income in EUR25.33m
  • Incorporated1992
  • Employees4.39k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CellaVision AB64.49m12.88m563.27m221.0047.039.2334.028.736.086.0830.4531.000.7831.766.663,185,965.0015.6415.3018.1818.2466.6269.0319.9719.981.99103.580.0574110.185.9413.1710.128.0030.458.45
Advanced Medical Solutions Group plc157.08m13.34m591.82m1.50k43.621.9921.993.770.0510.0510.60111.120.39771.704.91154,244.703.386.543.647.0654.4556.758.4914.826.80--0.270225.851.514.23-22.14-6.7115.6612.32
Paul Hartmann AG2.38bn59.53m703.60m10.05k11.690.61594.180.295216.7616.76671.22318.251.181.995.45234,407.103.193.874.195.3458.0056.712.702.981.317.680.208242.751.802.12-21.37-18.495.952.71
Draegerwerk AG & Co KGaA3.36bn116.40m813.33m16.39k6.870.55493.090.2426.206.20179.1976.781.122.545.02205,867.603.913.265.804.8743.6244.163.503.051.136.570.243211.3810.785.39271.0533.872.6455.73
El En SpA659.63m49.76m824.52m2.03k17.422.4213.161.250.62230.62238.254.490.91411.773.69316,823.507.027.4312.8913.5240.0338.837.687.631.19--0.1845--2.7814.88-12.4723.49-13.40--
Medartis Holding AG234.76m4.30m835.24m829.00189.122.9130.633.560.30880.308817.0420.070.53770.56744.96265,720.500.98450.19191.130.215380.5382.331.830.35423.154.030.32270.0015.9611.81110.70-31.825.37--
Revenio Group Oyj96.68m19.01m917.02m216.0048.229.2539.959.490.72050.72053.663.760.70695.507.60447,574.1013.9014.3316.7717.9051.0150.7319.6621.131.7928.490.152155.81-0.412525.80-12.1518.7217.676.30
Arjo AB (publ)996.57m47.59m947.80m6.94k22.981.556.900.9511.971.9741.2129.200.69574.406.511,651,221.003.313.554.515.5543.6844.014.765.410.66574.010.412343.0110.035.976.9010.15-8.8910.35
ChemoMetec A/S54.70m18.28m962.30m173.0053.3812.8746.5917.597.837.8323.4432.480.61120.7456.972,357,630.0020.4227.9624.4035.1078.8079.5733.4135.023.76--0.0073144.08-8.2218.37-23.7226.649.97-11.81
GVS SpA426.19m25.33m1.09bn4.39k49.273.5115.532.550.14570.14572.442.050.43032.006.1697,169.862.567.353.2510.8255.1258.745.9412.441.033.980.5461--9.5815.25-43.37-9.9716.08--
Biotage AB185.20m22.20m1.29bn667.0059.413.9233.576.983.123.1226.0547.360.42371.706.603,094,956.005.0810.745.8712.7762.9061.4011.9815.751.1416.130.062840.1119.5415.50-8.217.9714.051.30
Xvivo Perfusion AB62.03m10.72m1.41bn152.00128.217.8783.6722.693.953.9522.6964.280.34411.224.484,367,031.005.951.246.451.3374.1673.1417.284.763.27--0.01330.0043.8826.04398.2948.5721.35--
Oxford Nanopore Technologies PLC200.97m-190.56m1.63bn1.24k--2.48--8.09-0.187-0.1870.1970.6620.22650.73332.86135,499.20-21.47-21.12-24.63-24.6753.8953.90-94.82-81.853.36--0.0747---14.5739.15-69.74--8.92--
Data as of Sep 30 2024. Currency figures normalised to GVS SpA's reporting currency: Euro EUR

Institutional shareholders

15.53%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 30 Jun 20247.86m4.49%
Mediolanum Gestione Fondi SGRpAas of 29 Dec 20234.19m2.40%
T. Rowe Price International Ltd.as of 30 Jun 20242.70m1.54%
The Vanguard Group, Inc.as of 04 Jul 20242.49m1.42%
Amundi Asset Management SA (Investment Management)as of 03 Jul 20241.95m1.11%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 May 20231.74m0.99%
Fideuram Asset Management SGR SpAas of 28 Jun 20241.72m0.98%
Invesco Asset Management Ltd.as of 28 Jun 20241.65m0.94%
Fidelity Management & Research Co. LLCas of 30 Jun 20241.55m0.89%
Oddo BHF Asset Management SASas of 28 Jun 20241.34m0.76%
More ▼
Data from 31 Mar 2024 - 07 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.